Editor-in-Chief

Godefridus J. Peters

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.

HomePage

https://www.researchgate.net/profile/Godefridus_Peters

Research Interests

cancer biomarkers, apoptosis, lung diseases, cell culture, gene expression, pharmacokinetics, pharmacodynamics and pharmacogenetics of anticancer drugs, gastrointestinal cancers, translational research, animal models, drug metabolism and transport, influx and efflux proteins.

Contributions:

SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance

Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro

Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer

How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

Cancer drug resistance: a new perspective

Special Issue:

Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group

Submit a Manuscript